Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 15, Issue 5, Pages 535-541
Publisher
Oxford University Press (OUP)
Online
2013-01-30
DOI
10.1093/neuonc/nos324
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma
- (2012) Benjamin R. Kipp et al. HUMAN PATHOLOGY
- IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
- (2012) Sevin Turcan et al. NATURE
- A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation
- (2012) Robert B Jenkins et al. NATURE GENETICS
- Combinations of newly confirmed Glioma-Associated loci link regions on chromosomes 1 and 9 to increased disease risk
- (2011) Tun-Hsiang Yang et al. BMC Medical Genomics
- Genomic Profiles of Glioma
- (2011) Cameron Brennan Current Neurology and Neuroscience Reports
- Molecular subclassification of diffuse gliomas: Seeing order in the chaos
- (2011) Jason T. Huse et al. GLIA
- Chromosome 7p11.2 (EGFR) variation influences glioma risk
- (2011) Marc Sanson et al. HUMAN MOLECULAR GENETICS
- Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
- (2011) Albert Lai et al. JOURNAL OF CLINICAL ONCOLOGY
- Isocitrate dehydrogenase mutations in diffuse gliomas: clinical and aetiological implications
- (2011) R. Gupta et al. JOURNAL OF CLINICAL PATHOLOGY
- Cancer susceptibility variants and the risk of adult glioma in a US case–control study
- (2011) Kathleen M. Egan et al. JOURNAL OF NEURO-ONCOLOGY
- A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer
- (2011) Christopher A Haiman et al. NATURE GENETICS
- A germline variant in the TP53 polyadenylation signal confers cancer susceptibility
- (2011) Simon N Stacey et al. NATURE GENETICS
- Metabolism unhinged: IDH mutations in cancer
- (2011) John R Prensner et al. NATURE MEDICINE
- Distinct germ line polymorphisms underlie glioma morphologic heterogeneity
- (2011) Robert B. Jenkins et al. Cancer Genetics
- A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk
- (2010) Ulrika Andersson et al. ACTA ONCOLOGICA
- Inherited variation in immune genes and pathways and glioblastoma risk
- (2010) Judith A. Schwartzbaum et al. CARCINOGENESIS
- Genetic Risk Profiles Identify Different Molecular Etiologies for Glioma
- (2010) M. Simon et al. CLINICAL CANCER RESEARCH
- IDH1 and IDH2 Mutations Are Prognostic but not Predictive for Outcome in Anaplastic Oligodendroglial Tumors: A Report of the European Organization for Research and Treatment of Cancer Brain Tumor Group
- (2010) M. J. van den Bent et al. CLINICAL CANCER RESEARCH
- DNA Methylation, Isocitrate Dehydrogenase Mutation, and Survival in Glioma
- (2010) Brock C. Christensen et al. JNCI-Journal of the National Cancer Institute
- IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas
- (2010) C. Houillier et al. NEUROLOGY
- All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2
- (2010) M. Labussiere et al. NEUROLOGY
- Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma
- (2009) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas
- (2009) Christian Hartmann et al. ACTA NEUROPATHOLOGICA
- Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
- (2009) Marc Sanson et al. JOURNAL OF CLINICAL ONCOLOGY
- A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
- (2009) Outi Kilpivaara et al. NATURE GENETICS
- Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
- (2009) Margaret Wrensch et al. NATURE GENETICS
- Genome-wide association study identifies five susceptibility loci for glioma
- (2009) Sanjay Shete et al. NATURE GENETICS
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started